ArticleFrontiers in pharmacology2021

A Retrospective Cohort Study: Safety and Effectiveness of Elbasvir/Grazoprevir ± Ribavirin Compared With Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir ± Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Infection.

Hsuan-Yu Hung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.